TTM
−$37.19M
YoY change
-26.5%
5Y CAGR
—
Peak year (2018)
−$9.86M
Cumulative net income
−$293.29M
Net Income history chart for Spruce Biosciences (SPRB) from 2018 to 2025
Latest: −$38.97M
Net Income growth chart for Spruce Biosciences (SPRB) from 2018 to 2025
Latest: -26.5%
Net Income history table for Spruce Biosciences (SPRB) from 2018 to 2025
| 2025 | −$38.97M | -26.5% | +$14.07M | ||
| 2024 | −$53.04M | +10.7% | −$5.12M | ||
| 2023 | −$47.92M | +3.8% | −$1.74M | ||
| 2022 | −$46.18M | +9.2% | −$3.89M | ||
| 2021 | −$42.29M | +43.2% | −$12.75M | ||
| 2020 | −$29.54M | +123.2% | −$16.30M | ||
| 2019 | −$13.24M | +34.3% | −$3.38M | ||
| 2018 | −$9.86M | — | — |
- 2025−$38.97M-26.5%
- 2024−$53.04M+10.7%
- 2023−$47.92M+3.8%
- 2022−$46.18M+9.2%
- 2021−$42.29M+43.2%
- 2020−$29.54M+123.2%
- 2019−$13.24M+34.3%
- 2018−$9.86M—
Net Income values are taken from Spruce Biosciences's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Net Income at Spruce Biosciences (SPRB)
According to Spruce Biosciences's latest reported financial statements, the company's current net income (TTM) is −$37.19M. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Spruce Biosciences (SPRB) most recent annual net income stands at −$38.97M (2025) – declined 26.5% year-over-year.
The highest annual net income of −$9.86M was reported in 2018. The lowest in the available history was −$53.04M in 2024.
Spruce Biosciences Net Income by Year
Spruce Biosciences Net Income 2025: −$38.97M
2025's net income for Spruce Biosciences came in at −$38.97M, declined 26.5% below 2024.
Spruce Biosciences Net Income 2024: −$53.04M
Spruce Biosciences posted net income of −$53.04M in 2024, grew 10.7% from 2023. This figure represents the lowest annual value in the available history.
Spruce Biosciences Net Income 2023: −$47.92M
In 2023, Spruce Biosciences reported net income of −$47.92M, edged up 3.8% from 2022.
Spruce Biosciences Net Income 2022: −$46.18M
Spruce Biosciences net income in 2022 was −$46.18M, grew 9.2% from 2021.
Spruce Biosciences Net Income 2021: −$42.29M
Spruce Biosciences net income in 2021 was −$42.29M.
See more financial history for Spruce Biosciences (SPRB).
Sector peers by Net Income
Healthcare peers of Spruce Biosciences (SPRB), ranked by their latest net income
| $26.80B | |
| $20.64B | |
| $18.25B | |
| $15.97B | |
| $12.06B | |
| $10.26B | |
| $7.71B | |
| $4.23B |
- $26.80B
- $20.64B
- $18.25B
- $15.97B
- $12.06B
- $10.26B
- $7.71B
- $4.23B
Frequently asked questions
Spruce Biosciences (SPRB) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation